HMGB1 and neoplasm: Mechanistically, NE and HMGB1 released from NETs can bind to TLR-4 and TLR9, respectively, activating tumor cell proliferation, increasing mitochondrial biogenesis, and promoting the release of cytokines such as IL-6 and IL-8.